Recent RIGL News
- Rigel's Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease • PR Newswire (US) • 01/22/2025 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 01:15:12 PM
- Rigel Provides Business Update and 2025 Outlook • PR Newswire (US) • 01/13/2025 01:05:00 PM
- Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS • PR Newswire (US) • 01/09/2025 01:05:00 PM
- Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference • PR Newswire (US) • 01/08/2025 01:05:00 PM
- Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) • PR Newswire (US) • 01/03/2025 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/09/2024 09:15:15 PM
- Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition • PR Newswire (US) • 12/09/2024 05:02:00 PM
- Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS • PR Newswire (US) • 12/02/2024 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2024 01:01:34 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2024 01:01:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2024 01:01:06 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 10:18:08 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 08:33:13 PM
- Rigel to Present at the Jefferies London Healthcare Conference • PR Newswire (US) • 11/12/2024 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:22:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 09:06:40 PM
- Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update • PR Newswire (US) • 11/07/2024 09:01:00 PM
- Rigel Announces Six Poster Presentations at the 66th American Society of Hematology Annual Meeting and Exposition • PR Newswire (US) • 11/05/2024 02:05:00 PM
- Rigel Announces Conference Call and Webcast to Report Third Quarter 2024 Financial Results and Business Update • PR Newswire (US) • 10/31/2024 12:05:00 PM
- Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for GAVRETO® (pralsetinib) • PR Newswire (US) • 10/24/2024 08:35:00 PM
- Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE® • GlobeNewswire Inc. • 10/16/2024 02:00:00 PM
- Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) • PR Newswire (US) • 10/04/2024 12:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2024 08:01:11 PM
- Rigel to Present at the 2024 Cantor Global Healthcare Conference • PR Newswire (US) • 09/12/2024 12:05:00 PM
Luke Plants Featured in U.S. Department of the Interior Report to Congress on Strategic Review of National Orphan Well Program • ZEFIF • Jan 21, 2025 10:51 AM
North Bay Resources Acquires 70% Interest in the Bishop Gold Mill, Inyo County, California • NBRI • Jan 21, 2025 9:26 AM
HealthLynked Unveils Release of ARi: A Revolutionary AI-Powered Healthcare Assistant • HLYK • Jan 21, 2025 8:00 AM
Good Gaming Inc. Announces ViaOne Services' Intent to Purchase Up to 10% of Its Common Shares in the Open Market • GMER • Jan 16, 2025 8:30 AM
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases • AVAI • Jan 16, 2025 8:00 AM
VOCODIA HOLDINGS INC. (OTCMKTS: VHAI) and TRACCOM INC. (OTCMKTS: TRCC) have signed an MOU to form a Joint Venture that will Revolutionize Event Monitoring with Narrative AI • VHAI • Jan 15, 2025 2:53 PM